Building on Recent Results from Brain Tumor Clinical Trials to Develop New Therapies

The rapid translation of immune checkpoint inhibitors into the newly diagnosed setting is evidence of a paradigm shift in glioblastoma clinical trial design. This lecture offers physicians a practical review of the recent brain tumor clinical trials that show promising results in newly diagnosed glioblastoma patients. 

Target Audience

Neurologists, Neuro-Oncologists, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Radiation Oncologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Physician Assistants and Fellows.


  • Evaluate the current standard of care for newly diagnosed glioblastoma.
  • Describe the results from seminal studies using anti-angiogenic agents.
  • Discuss the implementation of immunotherapy in malignant brain tumors.
Additional information
  • Theeler, Brett J., and Mark R. Gilbert. "Advances in the treatment of newly diagnosed glioblastoma." BMC medicine 13.1 (2015): 1.
  • Jubb, Adrian M., et al. "Predicting benefit from anti-angiogenic agents in malignancy." Nature Reviews Cancer 6.8 (2006): 626-635.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ABIM MOC
  • 0.75 General certificate of attendance
Course opens: 
Course expires: 

Mark R. Gilbert, M.D. 
Senior Investigator and Chief, Neuro-Oncology Branch
National Cancer Institute and National Institute of Neurological Disorders and Stroke
Bethesda, Maryland

Mark R. Gilbert, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentations or discussions. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ABIM MOC
  • 0.75 General certificate of attendance

Accreditation Period

Course opens: 
Course expires: 
Please login or register to take this course.

Required Hardware/software

This site is best viewed on the two most recent stable releases of the following browsers for all public pages:

PCs Running Windows

  • Google Chrome (Preferred): Download free web browser for PC, Mac, phone and tablet. 
  • Internet Explorer (IE 11 and above recommended): You will be prompted to download videos before you are able to view. Click “download” to view video.  After a momentary pause, the recording will play. 
  • Mozilla Firefox: You may be prompted under the “This Connection is Untrusted” screen to add “” and “” under “add exceptions”.

Apple Computers Running OSX

This site uses a responsive design, which allows the page layout of elements to change depending on the screen resolution. Certain functionality may change based on the screen resolution of smaller screens, such as the number of columns in a table.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.